Gene Expression Changes Associated With the Progression of Intraductal Papillary Mucinous Neoplasms

Robert P. Jury, Bryan J. Thibodeau, Laura E. Fortier, Timothy J. Geddes, Samreen Ahmed, Barbara L. Pruetz, Maryam A. Farinola, George D. Wilson
2012 Pancreas  
Objectives: The diagnosis of high-grade intraductal papillary mucinous neoplasm (IPMN) is difficult to distinguish from low-grade IPMN. The aim of this study was to identify potential markers for the discrimination of high-grade and invasive (HgInv) IPMN from low-and moderate-grade dysplasia IPMN. Methods: Laser capture microdissection was used to isolate distinct foci of low-grade, moderate-grade, high-grade, and invasive IPMN from paraffin-embedded archival tissue from 14 patients who
more » ... t resection for IPMN. Most samples included multiple grades in the same specimen. Affymetrix Human Exon microarrays were used to compare low-and moderate-grade dysplasia IPMN with HgInv IPMN. Results: Sixty-two genes were identified as showing significant changes in expression (P e 0.05 and a 2-fold cutoff ), including up-regulation of 41 in HgInv IPMN. Changes in gene expression are associated with biological processes related to malignant behavior including cell motion, cell proliferation, response to hypoxia, and epithelial-to-mesenchymal transition. In addition, altered signaling in several transforming growth factor AYrelated pathways was exhibited in the progression of IPMN to malignancy. Conclusions: This study identifies a set of genes associated with the progression of IPMN to malignancy. These genes are potential markers that could be used to identify IPMN requiring surgical resection.
doi:10.1097/mpa.0b013e31823d7b36 pmid:22273699 fatcat:cl755a6wozcy3eb3wuxo2eg3ya